View the event
| Reference: | 4964 |
| Country: | Russian Federation |
| Multiple country event: | No |
| Region: | EURO |
| City: | Vladimir |
| Start date: | 23 September 2012 |
| End date: | 30 September 2012 |
| Estimated duration: | |
| Status: | Completed - Complété |
| | (The mission has taken place) |
|
| Title: | To monitor two sites of study “Impact on tuberculosis treatment of diagnostic and treatment strategies based on implementation o |
| Type: | Mission |
| Terms of Reference: | GeneXpert MTB-RIF study “Impact on tuberculosis treatment of diagnostic and treatment strategies based on implementation of Xpert MTB/RIF assay” has been initiated at the beginning of 2012 at two sites in Russian Federation: Central Tuberculosis Research Institute (CTRI) in Moscow and Oblast TB Dispensary in Vladimir. Data collection for second phase of the study based on the Xpert diagnostics was started on Summer 2012 in Vladimir. Monitoring visit for data verification and quality assurance was conducted at both study sites. |
| Training Opportunity: | No |
| Website: | |
| Purpose 1: | MDR-TB / XDR-TB |
| Purpose 2: | |
| Purpose 3: | |
| Other purpose: | |
|
| Entered by: | Center for Disease Control and Prevention (CDC) |
| Partner 1: | |
| Partner 2: | |
| Partner 3: | |
| Contact name: | Juia Ershova |
| Contact email: | jhe3@cdc.gov |
| Other agencies: | |
|
| Funding needs: | No |
| Funding source: | |
| Other funding source: | |
| Available funding: | $ 0 |
| Funding gap: | $ 0 |
| Global Fund reference: | |
|
| Comments: | |
| |
There are no experts (roster) associated with this event. There are no experts (non-roster) associated with this event.
Date Created: 6 March 2013
Entered By: CDC
|
